title: Evolution of gonadotropin deficiency in a patient with type II autosomal dominant GH deficiency.
abstract: BACKGROUND
  Type II isolated GH deficiency (IGHD type II) is caused by dominant negative splicing or point mutations of the GH-1 gene. Studies have suggested that dominant mutant GH forms prevent the secretion of wild-type GH, resulting in eventual cell death; surprisingly, some patients with these GH mutations develop other hormonal deficiencies (ACTH, TSH).
  
  
  METHODS
  The proband presented at the age of 2.3 years with IGHD. His father, also known to have been treated for IGHD as a child, had subsequently been lost to follow-up, having remained without treatment during this time. At re-evaluation at the age of 38 years, he complained of lack of stamina and poor libido. Clinical and biochemical assessment confirmed severe GHD, borderline ACTH insufficiency, suboptimal basal and stimulated gonadotropins, and a poor prolactin response to provocation. The basal testosterone concentration was low, and he complained of secondary infertility. Magnetic resonance imaging revealed anterior pituitary hypoplasia in both patients. Genetic testing revealed a heterozygous splicing mutation in GH-1 (intervening sequence-3 + 1G>A) in both patients, known to cause IGHD type II.
  
  
  METHODS
  The proband showed an excellent growth response to recombinant human GH (rhGH). His father, also treated with rhGH, showed improved quality of life on rhGH, but testosterone concentrations continued to decline, necessitating treatment with testosterone with symptomatic benefit but no improvement in semen quality.
  
  
  CONCLUSIONS
  This case supports recent experimental and clinical observations suggesting that the cytotoxicity associated with accumulation of dominant negative mutant 17.5 kDa GH causes a form of GHD that can evolve into multiple hormone deficiencies. Hence, patients diagnosed initially with IGHD type II require continued long-term clinical follow-up.
authors.affiliation: Biochemistry, Endocrinology and Metabolism Unit and London Centre for Paediatric Endocrinology, Institute of Child Health, London, UK.
authors.forename: James P G
authors.initials: JP
authors.lastname: Turton
authors.forename: Charles R
authors.initials: CR
authors.lastname: Buchanan
authors.forename: Iain C A F
authors.initials: IC
authors.lastname: Robinson
authors.forename: Simon J B
authors.initials: SJ
authors.lastname: Aylwin
authors.forename: Mehul T
authors.initials: MT
authors.lastname: Dattani
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000172:deficiency; D000328:Adult; D002675:Child, Preschool; D004393:Dwarfism, Pituitary / Q000235:genetics*; D005260:Female; D005799:Genes, Dominant; D006062:Gonadotropins / Q000172:deficiency*; D019382:Human Growth Hormone / Q000172:deficiency* / Q000235:genetics*; D006801:Humans; D008297:Male; D010375:Pedigree; D010641:Phenotype; D022821:RNA Splice Sites / Q000235:genetics
chemical_list: D006062:Gonadotropins; D022821:RNA Splice Sites; D019382:Human Growth Hormone; D000324:Adrenocorticotropic Hormone